A Phase II Study Of GW572016 In Squamous Cell Carcinoma Of The Head And Neck (SCCHN)
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Lapatinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Jan 2014 Actual end date is changed to 1 December 2006 according to ClinicalTrials.gov record.
- 14 Apr 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.